Initially, CCN2 was designated connective tissue growth factor (CTGF), owing to its mitogenic activity in fibroblasts [1], whereas the original name of CCN3 was nephroblastoma-overexpressed (NOV), since it was found to be overexpressed in a truncated form in nephroblastomas [2]. This evidence concerns the gene CCN3 and Wilms tumor.